Akovaz FDA Approval History
Akovaz (ephedrine sulfate) is a pressor agent administered parenterally to address clinically important hypotension in surgical settings.
Development timeline for Akovaz
|May 2, 2016||Approval Flamel Technologies Receives FDA Approval of Akovaz (ephedrine sulfate) for Surgical Hypotension|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.